Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: A multicenter retrospective study

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3948-3953

  Luster, Markus ^a,k   Handkiewicz Junak, Daria ^b   Grossi, Armando ^c   Zacharin, Margaret ^d,e   Taïeb, David ^f   Cruz, Ofelia ^g   Hitzel, Anne ^h   Casas, Juan Antonio Vallejo ⁱ   Mäder, Uwe ^a   Dottorini, Massimo E ^j  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d Centre for Molecular   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f TIMONE HOSPITAL   (France)

^g HOSPITAL SANT JOAN DE DÉU   (Spain)

^h CENTRE HENRI BECQUEREL   (France)

ⁱ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^j Perugia Hospital   (Italy)

^k UNIVERSITY OF ULM   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THYROTROPIN; THYROTROPIN;

ADULT; ARTICLE; BODY MASS; CHILD; CLINICAL TRIAL; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; THYROID CANCER; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 70349929492     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0593     Document Type: Article

References (20)

1. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon 3rd HR, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885
2. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91:926-932 (Pubitemid 43357760)
3. Dow KH, Ferrell BR, Anello C 1997 Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7:613-619 (Pubitemid 27371801)
4. Hänscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, Ladenson PW, Wahl RL, Schlumberger M, Ricard M, Driedger A, Kloos RT, Sherman SI, Haugen BR, Carriere V, Corone C, Reiners C 2006 Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med 47:648-654 (Pubitemid 46768466)
5. Remy H, Borget I, Leboulleux S, Guilabert N, Lavielle F, Garsi J, Bournaud C, Gupta S, Schlumberger M, Ricard M 2008 131I effective half-life and dosimetry in thyroid cancer patients. J Nucl Med 49:1445-1450
6. Ralli M, Cohan P, Lee K2005 Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer. J Endocrinol Invest 28:270-273
7. Leger AF, Pellan M, Dagousset F, Chevalier A, Keller I, Clerc J 2005 A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments. Br J Radiol 78: 428-432 (Pubitemid 40691747)
8. Song H, He B, Prideaux A, Du Y, Frey E, Kasecamp W, Ladenson PW, Wahl RL, Sgouros G 2006 Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases. J Nucl Med 47:1985-1994 (Pubitemid 47544986)
9. Hoe FM, Charron M, Moshang Jr T 2006 Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab 19:25-30 (Pubitemid 43257417)
10. Lau WF, Zacharin MR, Waters K, Wheeler G, Johnston V, Hicks RJ 2006 Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy. Intern Med J 36:564-570 (Pubitemid 44179831)
11. Jarzab B, Handkiewicz-Junak D, Wloch J 2005 Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 12:773-803 (Pubitemid 41815776)
12. Iorcansky S, Herzovich V, Qualey RR, Tuttle RM 2005 Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer. J Clin Endocrinol Metab 90:6553-6555 (Pubitemid 41759314)
13. Luster M, Lassmann M, Freudenberg LS, Reiners C 2007 Thyroid cancer in childhood: management strategy, including dosimetry and long-term results. Hormones (Athens) 6:269-278
14. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L 1997 Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 38:669-675 (Pubitemid 27204036)
15. Dottorini ME 2000 Differentiated thyroid carcinoma in childhood. Rays 25:245-255
16. Steliarova-Foucher E, Stiller CA, Pukkala E, Lacour B, Plesko I, Parkin DM 2006 Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2150-2169 (Pubitemid 44224059)
17. Vitale G, Lupoli GA, Ciccarelli A, Lucariello A, Fittipaldi MR, Fonderico F, Panico A, Lupoli G 2003 Influence of body surface area onserum peak thyrotropin (TSH) levels after recombinant human TSH administration. J Clin Endocrinol Metab 88:1319-1322 (Pubitemid 36337796)
18. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896 (Pubitemid 27408571)
19. 2007 Thryogen product label. Genzyme Corp., Cambridge, MA
20. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ 1997 AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven